<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Smith KS</submitter><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>Medical Research Council</funding><funding>NCI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>The Brain Tumour Charity</funding><funding>Wellcome Trust</funding><pagination>1012-1020</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9748853</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>609(7929)</volume><pubmed_abstract>Medulloblastoma, a malignant childhood cerebellar tumour, segregates molecularly into biologically distinct subgroups, suggesting that a personalized approach to therapy would be beneficial&lt;sup>1&lt;/sup>. Mouse modelling and cross-species genomics have provided increasing evidence of discrete, subgroup-specific developmental origins&lt;sup>2&lt;/sup>. However, the anatomical and cellular complexity of developing human tissues&lt;sup>3&lt;/sup>-particularly within the rhombic lip germinal zone, which produces all glutamatergic neuronal lineages before internalization into the cerebellar nodulus-makes it difficult to validate previous inferences that were derived from studies in mice. Here we use multi-omics to resolve the origins of medulloblastoma subgroups in the developing human cerebellum. Molecular signatures encoded within a human rhombic-lip-derived lineage trajectory aligned with photoreceptor and unipolar brush cell expression profiles that are maintained in group 3 and group 4 medulloblastoma, suggesting a convergent basis. A systematic diagnostic-imaging review of a prospective institutional cohort localized the putative anatomical origins of group 3 and group 4 tumours to the nodulus. Our results connect the molecular and phenotypic features of clinically challenging medulloblastoma subgroups to their unified beginnings in the rhombic lip in the early stages of human development.</pubmed_abstract><journal>Nature</journal><pubmed_title>Unified rhombic lip origins of group 3 and group 4 medulloblastoma.</pubmed_title><pmcid>PMC9748853</pmcid><funding_grant_id>GN-000518</funding_grant_id><funding_grant_id>R01 NS122902</funding_grant_id><funding_grant_id>R01 NS093009</funding_grant_id><funding_grant_id>R01 CA232143</funding_grant_id><funding_grant_id>R37 NS095733</funding_grant_id><funding_grant_id>R01 CA270785</funding_grant_id><funding_grant_id>KL2 TR001854</funding_grant_id><funding_grant_id>P50 HD103524</funding_grant_id><funding_grant_id>P30 CA021765</funding_grant_id><funding_grant_id>MR/R006237/1</funding_grant_id><funding_grant_id>R01 NS095733</funding_grant_id><funding_grant_id>R24 HD000836</funding_grant_id><funding_grant_id>P01 CA096832</funding_grant_id><funding_grant_id>R50 CA211481</funding_grant_id><pubmed_authors>Millman J</pubmed_authors><pubmed_authors>Mankad K</pubmed_authors><pubmed_authors>Iskusnykh IY</pubmed_authors><pubmed_authors>Deng M</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Smith KS</pubmed_authors><pubmed_authors>Bihannic L</pubmed_authors><pubmed_authors>Edwards A</pubmed_authors><pubmed_authors>Haldipur P</pubmed_authors><pubmed_authors>Scoggins M</pubmed_authors><pubmed_authors>Aldinger KA</pubmed_authors><pubmed_authors>Gajjar A</pubmed_authors><pubmed_authors>Overman LM</pubmed_authors><pubmed_authors>Hovestadt V</pubmed_authors><pubmed_authors>Millen KJ</pubmed_authors><pubmed_authors>Northcott PA</pubmed_authors><pubmed_authors>Hadley J</pubmed_authors><pubmed_authors>Onar-Thomas A</pubmed_authors><pubmed_authors>Robinson GW</pubmed_authors><pubmed_authors>Gudenas BL</pubmed_authors><pubmed_authors>Sjoboen AH</pubmed_authors><pubmed_authors>Gao Q</pubmed_authors><pubmed_authors>Golser J</pubmed_authors><pubmed_authors>Chizhikov VV</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Sheppard H</pubmed_authors><pubmed_authors>Tao R</pubmed_authors><pubmed_authors>Orr BA</pubmed_authors><pubmed_authors>Patay Z</pubmed_authors><pubmed_authors>Glass IA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unified rhombic lip origins of group 3 and group 4 medulloblastoma.</name><description>Medulloblastoma, a malignant childhood cerebellar tumour, segregates molecularly into biologically distinct subgroups, suggesting that a personalized approach to therapy would be beneficial&lt;sup>1&lt;/sup>. Mouse modelling and cross-species genomics have provided increasing evidence of discrete, subgroup-specific developmental origins&lt;sup>2&lt;/sup>. However, the anatomical and cellular complexity of developing human tissues&lt;sup>3&lt;/sup>-particularly within the rhombic lip germinal zone, which produces all glutamatergic neuronal lineages before internalization into the cerebellar nodulus-makes it difficult to validate previous inferences that were derived from studies in mice. Here we use multi-omics to resolve the origins of medulloblastoma subgroups in the developing human cerebellum. Molecular signatures encoded within a human rhombic-lip-derived lineage trajectory aligned with photoreceptor and unipolar brush cell expression profiles that are maintained in group 3 and group 4 medulloblastoma, suggesting a convergent basis. A systematic diagnostic-imaging review of a prospective institutional cohort localized the putative anatomical origins of group 3 and group 4 tumours to the nodulus. Our results connect the molecular and phenotypic features of clinically challenging medulloblastoma subgroups to their unified beginnings in the rhombic lip in the early stages of human development.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-29T02:17:08.578Z</modification><creation>2025-02-19T02:21:56.942Z</creation></dates><accession>S-EPMC9748853</accession><cross_references><pubmed>36131015</pubmed><doi>10.1038/s41586-022-05208-9</doi></cross_references></HashMap>